Actively Recruiting
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
Led by University of Southern California · Updated on 2026-05-01
140
Participants Needed
1
Research Sites
465 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.
CONDITIONS
Official Title
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with degenerative lumbar disease
- Age between 18 and 75 years
- Scheduled for open primary lumbar fusion surgery involving one to three levels
You will not qualify if you...
- Current nightly use of a sleep aid
- Diagnosis of insomnia or sleep apnea
- History of delirium with opiates or zolpidem
- Allergy to opiates or zolpidem
- Previous lumbar spine surgery
- Undergoing minimally invasive lumbar fusion
- Lumbar fusion for fracture, infection, tumor, or inflammatory spondyloarthropathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Keck Medical Center of USC
Los Angeles, California, United States, 90033
Actively Recruiting
Research Team
P
Pui Yan, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here